Braveheart, Attovia, Apnimed join gene therapy firm Scribe in July IPO rush
Seeking Alpha ·
A slew of biotechs have disclosed their IPO plans in July, with Attovia Therapeutics ( ATTO ), a biotech focused on immune-mediated diseases, and heart drug developer Braveheart ( BRVE ) announcing their intentions to go public this week.
DYAX Investor Sentiment
Bullish (Long) 40% · Bearish (Short) 60%
300 participants